Global Allergy Immunotherapy Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Allergy Immunotherapy Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Allergy Immunotherapy Market Size Growth Rate by Type
  • 1.4.2 Subcutaneous Immunotherapy
  • 1.4.3 Sublingual Immunotherapy
• 1.3 Market by Application
  • 1.3.1 Global Allergy Immunotherapy Market Size Growth Rate by Application
  • 1.3.2 Allergic Rhinitis
  • 1.3.3 Allergic Asthma
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Allergy Immunotherapy Sales Estimates and Forecasts 2016-2027
• 2.2 Global Allergy Immunotherapy Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Allergy Immunotherapy Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Allergy Immunotherapy Regions by Sales
  • 2.4.1 Global Top Allergy Immunotherapy Regions by Sales (2016-2021)
  • 2.4.2 Global Top Allergy Immunotherapy Regions by Sales (2022-2027)
• 2.5 Global Top Allergy Immunotherapy Regions by Revenue
  • 2.5.1 Global Top Allergy Immunotherapy Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Allergy Immunotherapy Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Allergy Immunotherapy Sales by Manufacturers
  • 3.1.1 Global Top Allergy Immunotherapy Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Allergy Immunotherapy Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Allergy Immunotherapy Sales in 2020
• 3.2 Global Allergy Immunotherapy Revenue by Manufacturers
  • 3.2.1 Global Top Allergy Immunotherapy Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Allergy Immunotherapy Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Allergy Immunotherapy Revenue in 2020
• 3.3 Global Allergy Immunotherapy Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Allergy Immunotherapy Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Allergy Immunotherapy Sales by Type
  • 4.1.1 Global Allergy Immunotherapy Historical Sales by Type (2016-2021)
  • 4.1.2 Global Allergy Immunotherapy Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Allergy Immunotherapy Sales Market Share by Type (2016-2027)
• 4.2 Global Allergy Immunotherapy Revenue by Type
  • 4.2.1 Global Allergy Immunotherapy Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Allergy Immunotherapy Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Allergy Immunotherapy Revenue Market Share by Type (2016-2027)
• 4.3 Global Allergy Immunotherapy Price by Type
  • 4.3.1 Global Allergy Immunotherapy Price by Type (2016-2021)
  • 4.3.2 Global Allergy Immunotherapy Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Allergy Immunotherapy Sales by Application
  • 5.1.1 Global Allergy Immunotherapy Historical Sales by Application (2016-2021)
  • 5.1.2 Global Allergy Immunotherapy Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Allergy Immunotherapy Sales Market Share by Application (2016-2027)
• 5.2 Global Allergy Immunotherapy Revenue by Application
  • 5.2.1 Global Allergy Immunotherapy Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Allergy Immunotherapy Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Allergy Immunotherapy Revenue Market Share by Application (2016-2027)
• 5.3 Global Allergy Immunotherapy Price by Application
  • 5.3.1 Global Allergy Immunotherapy Price by Application (2016-2021)
  • 5.3.2 Global Allergy Immunotherapy Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Allergy Immunotherapy Market Size by Type
  • 6.1.1 North America Allergy Immunotherapy Sales by Type (2016-2027)
  • 6.1.2 North America Allergy Immunotherapy Revenue by Type (2016-2027)
• 6.2 North America Allergy Immunotherapy Market Size by Application
  • 6.2.1 North America Allergy Immunotherapy Sales by Application (2016-2027)
  • 6.2.2 North America Allergy Immunotherapy Revenue by Application (2016-2027)
• 6.3 North America Allergy Immunotherapy Market Size by Country
  • 6.3.1 North America Allergy Immunotherapy Sales by Country (2016-2027)
  • 6.3.2 North America Allergy Immunotherapy Revenue by Country (2016-2027)

7 Europe

• 7.1 Europe Allergy Immunotherapy Market Size by Type
  • 7.1.1 Europe Allergy Immunotherapy Sales by Type (2017-2027)
  • 7.1.2 Europe Allergy Immunotherapy Revenue by Type (2017-2027)
• 7.2 Europe Allergy Immunotherapy Market Size by Application
  • 7.2.1 Europe Allergy Immunotherapy Sales by Application (2017-2027)
  • 7.2.2 Europe Allergy Immunotherapy Revenue by Application (2017-2027)
• 7.3 Europe Allergy Immunotherapy Market Size by Country
  • 7.3.1 Europe Allergy Immunotherapy Sales by Country (2017-2027)
  • 7.3.2 Europe Allergy Immunotherapy Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Allergy Immunotherapy Market Size by Type
  • 8.1.1 Asia Pacific Allergy Immunotherapy Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Allergy Immunotherapy Revenue by Type (2018-2027)
• 8.2 Asia Pacific Allergy Immunotherapy Market Size by Application
  • 8.2.1 Asia Pacific Allergy Immunotherapy Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Allergy Immunotherapy Revenue by Application (2018-2027)
• 8.3 Asia Pacific Allergy Immunotherapy Market Size by Region
  • 8.3.1 Asia Pacific Allergy Immunotherapy Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Allergy Immunotherapy Revenue by Region (2018-2027)

9 Latin America

• 9.1 Latin America Allergy Immunotherapy Market Size by Type
  • 9.1.1 Latin America Allergy Immunotherapy Sales by Type (2019-2027)
  • 9.1.2 Latin America Allergy Immunotherapy Revenue by Type (2019-2027)
• 9.2 Latin America Allergy Immunotherapy Market Size by Application
  • 9.2.1 Latin America Allergy Immunotherapy Sales by Application (2019-2027)
  • 9.2.2 Latin America Allergy Immunotherapy Revenue by Application (2019-2027)
• 9.3 Latin America Allergy Immunotherapy Market Size by Country
  • 9.3.1 Latin America Allergy Immunotherapy Sales by Country (2019-2027)
  • 9.3.2 Latin America Allergy Immunotherapy Revenue by Country (2019-2027)

6 Middle East and Africa

• 6.1 Middle East and Africa Allergy Immunotherapy Market Size by Type
  • 6.1.1 Middle East and Africa Allergy Immunotherapy Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Allergy Immunotherapy Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Allergy Immunotherapy Market Size by Application
  • 6.2.1 Middle East and Africa Allergy Immunotherapy Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Allergy Immunotherapy Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Allergy Immunotherapy Market Size by Country
  • 6.3.1 Middle East and Africa Allergy Immunotherapy Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Allergy Immunotherapy Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 ALK-Abello
  • 11.1.1 ALK-Abello Corporation Information
  • 11.1.2 ALK-Abello Overview
  • 11.1.3 ALK-Abello Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 ALK-Abello Allergy Immunotherapy Product Description
  • 11.1.5 ALK-Abello Related Developments
• 11.2 Stallergenes Greer
  • 11.2.1 Stallergenes Greer Corporation Information
  • 11.2.2 Stallergenes Greer Overview
  • 11.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 Stallergenes Greer Allergy Immunotherapy Product Description
  • 11.2.5 Stallergenes Greer Related Developments
• 11.3 Merck
  • 11.3.1 Merck Corporation Information
  • 11.3.2 Merck Overview
  • 11.3.3 Merck Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Merck Allergy Immunotherapy Product Description
  • 11.3.5 Merck Related Developments
• 11.4 Allergy Therapeutics
  • 11.4.1 Allergy Therapeutics Corporation Information
  • 11.4.2 Allergy Therapeutics Overview
  • 11.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 Allergy Therapeutics Allergy Immunotherapy Product Description
  • 11.4.5 Allergy Therapeutics Related Developments
• 11.5 HAL
  • 11.5.1 HAL Corporation Information
  • 11.5.2 HAL Overview
  • 11.5.3 HAL Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 HAL Allergy Immunotherapy Product Description
  • 11.5.5 HAL Related Developments
• 11.6 Holister Stier
  • 11.6.1 Holister Stier Corporation Information
  • 11.6.2 Holister Stier Overview
  • 11.6.3 Holister Stier Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Holister Stier Allergy Immunotherapy Product Description
  • 11.6.5 Holister Stier Related Developments
• 11.7 Leti
  • 11.7.1 Leti Corporation Information
  • 11.7.2 Leti Overview
  • 11.7.3 Leti Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Leti Allergy Immunotherapy Product Description
  • 11.7.5 Leti Related Developments
• 11.1 ALK-Abello
  • 11.1.1 ALK-Abello Corporation Information
  • 11.1.2 ALK-Abello Overview
  • 11.1.3 ALK-Abello Allergy Immunotherapy Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 ALK-Abello Allergy Immunotherapy Product Description
  • 11.1.5 ALK-Abello Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Allergy Immunotherapy Value Chain Analysis
• 12.2 Allergy Immunotherapy Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Allergy Immunotherapy Production Mode & Process
• 12.4 Allergy Immunotherapy Sales and Marketing
  • 12.4.1 Allergy Immunotherapy Sales Channels
  • 12.4.2 Allergy Immunotherapy Distributors
• 12.5 Allergy Immunotherapy Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Allergy Immunotherapy Industry Trends
• 13.2 Allergy Immunotherapy Market Drivers
• 13.3 Allergy Immunotherapy Market Challenges
• 13.4 Allergy Immunotherapy Market Restraints

14 Key Findings in The Global Allergy Immunotherapy Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details